利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

43 条记录 (耗时 0.049 秒)

    Composition and method for enabling proliferation of pluripotent stem cells
    2.
    发明申请
    Composition and method for enabling proliferation of pluripotent stem cells 有权
    使多能干细胞增殖的组成和方法

    公开(公告)号：US20100323443A1

    公开(公告)日：2010-12-23

    申请号：US12583750

    申请日：2009-08-25

    申请人： Anna Domogatskaya ,  Sergey Rodin ,  Karl Tryggvason

    发明人： Anna Domogatskaya ,  Sergey Rodin ,  Karl Tryggvason

    IPC分类号： C12N5/00

    CPC分类号： C12N5/0606 ,  C12N2533/52

    摘要： The present disclosure is directed to the development of compositions, such as extracellular matrices, and processes for using the same, that both maintain stem cells in vitro pluripotency and enable self-renewal. In this regard, it has been discovered that when pluripotent mouse and human embryonic stem cells are cultured on plates coated with recombinant laminin-10 (laminin-511) or their functional domains, in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferated and maintained their pluripotency.

    摘要翻译： 本公开涉及组合物的发展，例如细胞外基质及其使用方法，其既维持干细胞体外多能性并且实现自我更新。 在这方面，已经发现，当在不存在分化抑制剂或饲养细胞的情况下，将多能小鼠和人胚胎干细胞培养在用重组层粘连蛋白-10（层粘连蛋白-51）或其功能结构域包被的平板上时，胚胎干 细胞增殖并维持其多能性。

    Laminin 8 and methods for its use
    5.
    发明授权
    Laminin 8 and methods for its use 有权
    层粘蛋白8及其使用方法

    公开(公告)号：US06638907B1

    公开(公告)日：2003-10-28

    申请号：US09561818

    申请日：2000-04-28

    申请人： Jarrko Kortesmaa ,  Karl Tryggvason

    发明人： Jarrko Kortesmaa ,  Karl Tryggvason

    IPC分类号： C07K1400

    CPC分类号： G01N31/22 ,  A61K38/00 ,  C07K14/78 ,  C07K2319/00 ,  C07K2319/02 ,  Y10S977/904 ,  Y10S977/91 ,  Y10S977/915

    摘要： The present invention provides substantially purified laminin 8, methods for making recombinant laminin 8, cells that express recombinant laminin 8, and methods for using the recombinant laminin 8 to accelerate the healing of injuries to vascular tissue and tissue of mesenchymal origin, and to promote cell attachment and migration.

    摘要翻译： 本发明提供基本上纯化的层粘连蛋白8，用于制备重组层粘连蛋白8，表达重组层粘连蛋白8的细胞的方法，以及使用重组层粘连蛋白8加速维管组织和间充质来源组织的损伤愈合的方法，以及促进细胞 附件和迁移。

    Method for determining the nucleotide sequence of the gene for the &agr;5(IV) chain of human type IV collagen
    6.
    发明授权
    Method for determining the nucleotide sequence of the gene for the &agr;5(IV) chain of human type IV collagen 失效
    确定人IV型胶原的α5（IV）链的基因的核苷酸序列的方法

    公开(公告)号：US06576418B1

    公开(公告)日：2003-06-10

    申请号：US08692989

    申请日：1996-08-07

    申请人： Karl Tryggvason ,  Sirkka L. Hostikka ,  Jing Zhou

    发明人： Karl Tryggvason ,  Sirkka L. Hostikka ,  Jing Zhou

    IPC分类号： C12Q168

    CPC分类号： C07K14/78 ,  C12Q1/6869 ,  C12Q1/6876 ,  C12Q1/6881 ,  C12Q1/6883 ,  C12Q2600/156

    摘要： The present invention relates to a method for isolating and identifying the nucleotide sequence of the human gene for the type IV collagen &agr;5(IV) chain. The present invention is directed to the determination of the nucleotide sequence of the gene for the &agr;5(IV) collagen chain in individuals by any method known to the art, e.g. cloning from genomic DNA libraries or amplifying gene regions with the polymerase chain reaction (PCR) and studying their physical properties or nucleotide sequences. In addition, the invention is directed to the use of the nucleotide sequences of the &agr;5(IV) gene to amplify or identify the nucleotide sequences of the &agr;5(IV) gene.

    摘要翻译： 本发明涉及用于分离和鉴定IV型胶原α5（IV）链的人基因的核苷酸序列的方法。 本发明涉及通过本领域已知的任何方法测定个体中α5（IV）胶原链的基因的核苷酸序列，例如， 通过聚合酶链反应（PCR）从基因组DNA文库克隆或扩增基因区域，并研究其物理性质或核苷酸序列。 此外，本发明涉及α5（IV）基因的核苷酸序列用于扩增或鉴定α5（IV）基因的核苷酸序列的用途。

    Method for determining the nucleotide sequence of a novel .alpha.5(IV) chain of human type IV collagen
    7.
    发明授权
    Method for determining the nucleotide sequence of a novel .alpha.5(IV) chain of human type IV collagen 失效
    确定人IV型胶原新型α5（IV）链的核苷酸序列的方法

    公开(公告)号：US5114840A

    公开(公告)日：1992-05-19

    申请号：US377238

    申请日：1989-07-07

    申请人： Karl Tryggvason ,  Sirkka L. Hostikka

    发明人： Karl Tryggvason ,  Sirkka L. Hostikka

    IPC分类号： C07K14/78 ,  C12Q1/68

    CPC分类号： C12Q1/6883 ,  C07K14/78 ,  C12Q2600/156

    摘要： The present invention provides for a method for isolating and partially characterizing the nucleotide sequence for a novel polypeptide chain of human basement membrane (type IV) collagen, referred to as the .alpha.5(IV) polypeptide chain. The invention provides for the use of the identified nucleotide sequence (or DNA fragments thereof) to detect mutations in individual genes specific for the .alpha.5(IV) chain which can, directly or indirectly, produce several human diseases. Moreover, the invention also relates to procedures for determining genetic or acquired disorders of basement membranes using the identified nucleotide sequence (or DNA fragments thereof) of the .alpha.5(IV) polypeptide chain, probes specific to DNA fragments of said nucleotide sequence,or antibodies to the nucleotide sequence or DNA parts thereof. Also, the invention relates to the use of gene fragments generated through amplification from human genomic or cloned DNA for detection and analysis of the gene, such as in detection of mutations.

    摘要翻译： 本发明提供了用于分离和部分表征人基底膜（IV型）胶原（称为α5（IV）多肽链）的新型多肽链的核苷酸序列的方法。 本发明提供了鉴定的核苷酸序列（或其DNA片段）用于检测可直接或间接产生若干人类疾病的α5（IV）链特异性的个体基因中的突变。 此外，本发明还涉及使用所确定的α5（IV）多肽链的核苷酸序列（或其DNA片段），所述核苷酸序列的DNA片段特异的探针或抗体来确定基底膜遗传或获得性疾病的方法 到其核苷酸序列或DNA部分。 此外，本发明涉及通过来自人基因组或克隆DNA的扩增产生的基因片段的用途来检测和分析该基因，例如检测突变。

    Antibodies against domains of laminin-332
    9.
    发明授权
    Antibodies against domains of laminin-332 有权
    针对层粘连蛋白332结构域的抗体

    公开(公告)号：US08545845B2

    公开(公告)日：2013-10-01

    申请号：US13060358

    申请日：2009-06-18

    申请人： Karl Tryggvason ,  Sirpa Anne Kristiina Salo

    发明人： Karl Tryggvason ,  Sirpa Anne Kristiina Salo

    IPC分类号： A61K39/395

    CPC分类号： C07K16/18 ,  A61K39/395 ,  A61K2039/505 ,  A61K2039/507 ,  A61K2300/00

    摘要： Antibodies against various domains of laminin-332 are discussed herein. The antibodies reduce the adhesion and matrix binding properties of laminin-332, inhibiting tumor growth and metastasis in vivo. Pharmaceutical compositions and methods of using the antibodies for diagnostic, prophylactic, and/or therapeutic purposes are disclosed.

    摘要翻译： 本文讨论针对层粘连蛋白-323的各个结构域的抗体。 抗体降低层粘连蛋白-332的粘附和基质结合特性，抑制体内肿瘤的生长和转移。 公开了用于诊断，预防和/或治疗目的的抗体的药物组合物和方法。